scholarly article | Q13442814 |
P2093 | author name string | Wei Fan | |
De Shi | |||
Tong Zhou | |||
Xiao-Ting Wu | |||
Yue-Chun Li | |||
Xiong Huang | |||
Ye-Jiang Zhou | |||
Yu-Xia Xiong | |||
P2860 | cites work | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
Protean PTEN: form and function | Q24613810 | ||
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells | Q28344025 | ||
Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary | Q30649065 | ||
Tissue expression of VEGF as a prognostic factor in early cervical squamous cell carcinoma | Q31036915 | ||
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis | Q33723736 | ||
PTEN controls tumor-induced angiogenesis | Q35282160 | ||
Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma | Q36179792 | ||
Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. | Q36619048 | ||
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells | Q37116110 | ||
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis | Q40679766 | ||
PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines | Q40833639 | ||
Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. | Q40916972 | ||
MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. | Q42825696 | ||
Promoter methylation and silencing of PTEN in gastric carcinoma | Q43918868 | ||
Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives | Q43959642 | ||
Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer | Q43966008 | ||
The effects of PTEN gene on migration and FAK phosphorylation of SMMC-7721 human hepatocarcinoma cell line | Q44289639 | ||
Tumour suppressor gene expression correlates with gastric cancer prognosis | Q44401645 | ||
PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus | Q44702044 | ||
Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo | Q45869247 | ||
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma | Q45952675 | ||
PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma | Q48132410 | ||
PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas. | Q48204599 | ||
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. | Q48230264 | ||
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. | Q48829821 | ||
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. | Q52549220 | ||
Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. | Q52933275 | ||
MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer | Q57648894 | ||
TGF-β1 Modulated the Expression of α5β1 Integrin and Integrin-Mediated Signaling in Human Hepatocarcinoma Cells | Q57662206 | ||
Colorectal carcinomas and PTEN/MMAC1 gene mutations | Q62661743 | ||
PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects | Q64379300 | ||
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas | Q73271272 | ||
Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis | Q73295499 | ||
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer | Q73814904 | ||
Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma | Q77340398 | ||
Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis | Q77599299 | ||
PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation | Q78026206 | ||
Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer | Q79366153 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 3225-3229 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer | |
P478 | volume | 10 |
Q57196623 | A clinicopathological study of basaloid squamous carcinoma of the esophagus |
Q35943250 | Clinical implications of PTEN and VEGF expression status, as well as microvessel density in esophageal squamous cell carcinoma |
Q35915549 | Differential Requirement for Pten Lipid and Protein Phosphatase Activity during Zebrafish Embryonic Development |
Q48649622 | Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN. |
Q36099292 | Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo |
Q36253306 | Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies |
Q36006472 | Fine-Tuning of Pten Localization and Phosphatase Activity Is Essential for Zebrafish Angiogenesis |
Q33843200 | MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog |
Q92702101 | PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? |
Q35952035 | PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer |
Q37394161 | PTEN-mediated pathways and their association with treatment-resistant prostate cancer |
Q35374477 | Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective |
Q33997970 | Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx |
Q40348015 | VEGF expression is associated with negative estrogen receptor status in patients with breast cancer |
Q34030791 | YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models |